# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
P3 Health Partners (NASDAQ:PIII) affirms FY2025 sales outlook from $1.350 billion-$1.500 billion to $1.350 billion-$1.500 billi...
P3 Health Partners (NASDAQ:PIII) reported quarterly losses of $(6.23) per share which missed the analyst consensus estimate of ...
P3 Health Partners (NASDAQ:PIII) affirms FY2025 sales outlook from $1.35 billion-$1.50 billion to $1.35 billion-$1.50 billion v...
P3 Health Partners (NASDAQ:PIII) reported quarterly losses of $(6.28) per share. This is a 20.1 percent increase over losses of...